SecBot SecBot
10-Q/A ·Filed Nov 6, 2026

REPL

Replimune Group, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4d 2h ago SEC0001104659-26-123850
Amended quarterly report (potential restatement)
Actionable Insight • Neutral

The disclosed 10b5-1 plans allow executives to sell a combined 748,156 shares (about 0.8% of shares outstanding) over time. Monitor insider trading patterns and any subsequent Form 4 filings for actual sales.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$22.26
T+0 close · Nov 6, 2026 · via day close
Latest settled
+4.58%
T+1 · $23.28
vs SPY
+4.95%
α at T+1
Next horizon
T+5
in 6d
  1. T+0 · Nov 9 $22.26entry
  2. T+1 · 11h ago +4.58%α +4.95% · $23.28
  3. T+5 · in 6d Pending
  4. T+20 · in 28d Pending
  5. T+60 · in 3mo Pending
Loading chart...

Executive Summary

Replimune Group filed an amended 10-Q to add previously omitted Rule 10b5-1 trading plan disclosures for three top executives: Executive Chair Philip Astley-Sparke (488,119 shares), CEO Sushil Patel (99,665 shares), and CMO Konstantinos Xynos (160,372 shares). No financial statements were restated; the amendment only corrects Part II Item 5 of the original filing.

Key Facts

  • Amendment adds Rule 10b5-1 trading arrangements for three executives inadvertently omitted from the original 10-Q filed Oct 28, 2026
  • Philip Astley-Sparke (Executive Chair) adopted plan on 08/21/2026 covering 488,119 shares, expiring 03/15/2028
  • Sushil Patel (CEO) adopted plan on 08/21/2026 covering 99,665 shares, expiring 08/20/2027
  • Konstantinos Xynos (CMO) adopted plan on 08/20/2026 covering 160,372 shares, expiring 08/30/2027
  • No changes to financial statements; no restatement of previously reported figures

Financial Impact

No financial impact; administrative correction only

Risk Factors

  • Potential insider selling overhang from the disclosed 10b5-1 plans, though plans were adopted months ago and are pre-scheduled

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
87% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
10-Q/A Filing (Primary)0001104659-26-123850
Document: tm2629174d1_ex31-2.htm0001104659-26-123850
Document: tm2629174d1_ex31-1.htm0001104659-26-123850
Document: 0001104659-26-123850-index-headers.html0001104659-26-123850
Document: 0001104659-26-123850-index.html0001104659-26-123850
Document: 0001104659-26-123850.txt0001104659-26-123850

Track record

31 reports on REPL

Performance horizon

9 of 13 bullish or bearish reports moved the stock their way by T+60. Best: +188.35% at T+20 after the Jul 30, 2026 report. 13 of 14 went positive at some point.

Filters
  1. Nov 10, 2026today Insider Cluster Neutral 2/10 Entry $23.47 Now $23.28 −0.81% settles Feb 9
  2. Nov 10, 2026today SC 13G Neutral 3/10 Entry $22.00 Now $23.28 +5.82% settles Feb 8
  3. Nov 9, 20261d ago 144 Neutral 2/10 Entry $22.51 Now $23.28 +3.42% settles Feb 8
  4. Nov 9, 20261d ago SC 13G/A Neutral 2/10 Entry $22.26 Now $23.28 +4.58% settles Feb 5
  5. Nov 6, 20264d ago 10-Q/A Neutral 3/10 Viewing Entry $22.26 Now $23.28 +4.58% settles Feb 5
  6. Nov 4, 20266d ago Institutional Cluster Bearish 4/10 Entry $20.69 Now $23.28 −12.52% settles Feb 2
  7. Nov 3, 20267d ago 144 Neutral 2/10 Entry $20.69 Now $23.28 +12.52% settles Feb 2
  8. Nov 2, 20268d ago 144 Neutral 2/10 Entry $20.65 Now $23.28 +12.74% settles Feb 1
  9. Oct 30, 202611d ago 144 Neutral 2/10 Entry $19.49 Now $23.28 +19.45% settles Jan 29
  10. Oct 28, 202613d ago 144 Neutral 2/10 Entry $17.39 Now $23.28 +33.87% settles Jan 27
Showing 10 of 31

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026